Efficacy of combination of immune checkpoint inhibitors, chemotherapy, and targeted therapy in advanced/refractory cancer. A phase Ib/II study of pacritinib, an interleukin 1 receptor associated ...
A potential novel therapeutic target for invasive soft tissue sarcoma detected through tumor immune microenvironment and genetic profile analyses. This is an ASCO Meeting Abstract from the 2024 ASCO ...
Alveolar soft part sarcoma (ASPS) is a rare soft-tissue sarcoma with a poor prognosis and no established therapy. Recently, encouraging responses to immune checkpoint inhibitors have been reported. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results